Sagimet Biosciences Inc (SGMT) PT Lowered to $27 at Citizens on Dilution From Concurrent Financing

October 1, 2026 4:17 AM EDT Send to a Friend
Citizens analyst Jonathan Wolleben lowered the price target on Sagimet Biosciences Inc (NASDAQ: SGMT) to $27.00 (from $29.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login